FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

FDA Discusses Optimizing Advisory Committees

FDA commissioner Robert Califf and other top officials outline areas the agency believes can be optimized to help improve the advice received from adv...

latest-news-card-1
Medical Devices

FDA Approves Motiva Breast Implants

FDA approves Establishment Labs Holdings Motiva SmoothSilk Ergonomix and Motiva SmoothSilk Round breast implants for breast augmentation.

latest-news-card-1
Medical Devices

4 Dental Device Performance Criteria Guides

CDRH posts four dental final guidances under its Performance Criteria for Safety and Performance Based Pathway program.

latest-news-card-1
Human Drugs

Dupixent Approved for COPD Add On

FDA approves Sanofi and Regenerons Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive...

latest-news-card-1
Human Drugs

FDA OKs New Schizophrenia Drug

FDA approves Bristol-Myers Squibbs Cobenfy (xanomeline and trospium chloride) capsules for treating schizophrenia in adults.

latest-news-card-1
Federal Register

Advisory Committee Consumer Reps Sought

Federal Register notice: FDA seeks consumer organizations interested in participating in the selection process for voting or nonvoting consumer repres...

latest-news-card-1
Federal Register

OMB Clears 4 Informaton Collections

Federal Register notice: FDA announces that four information collections have been approved by OMB.

latest-news-card-1
Biologics

Appeals Court Gives FDA a Win on Stem Cells

The U.S. 9th Circuit Court of Appeals reverses an earlier California lower court decision that ruled a stem cell treatment firm is exempt from FDA reg...

latest-news-card-1
Human Drugs

FDA-passed Parkinsons Drug Part of Falsified Research Probe

An investigation by the journal Science questions the data behind a Parkinsons drug under development by Prothena and based on falsified research invo...

latest-news-card-1
Human Drugs

FDA Full Approval for Lillys Retevmo

FDA grants Eli Lilly full approval for Retevmo (selpercatinib) for certain adult and pediatric patients two years of age and older with advanced or me...